Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
20.45
-0.05 (-0.24%)
At close: Nov 20, 2024, 4:00 PM
20.47
+0.02 (0.10%)
Pre-market: Nov 21, 2024, 4:19 AM EST
Genmab Employees
Genmab had 2,204 employees as of December 31, 2023. The number of employees increased by 544 or 32.77% compared to the previous year.
Employees
2,204
Change (1Y)
544
Growth (1Y)
32.77%
Revenue / Employee
$1,346,609
Profits / Employee
$319,077
Market Cap
12.93B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2,204 | 544 | 32.77% |
Dec 31, 2022 | 1,660 | 448 | 36.96% |
Dec 31, 2021 | 1,212 | 431 | 55.19% |
Dec 31, 2020 | 781 | 233 | 42.52% |
Dec 31, 2019 | 548 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Fresenius Medical Care AG | 119,845 |
Tenet Healthcare | 106,500 |
Universal Health Services | 96,700 |
DaVita | 70,000 |
Revvity | 11,500 |
Avantor | 7,570 |
Incyte | 2,524 |
Neurocrine Biosciences | 1,400 |
GMAB News
- 11 days ago - Genmab A/S (GMAB) Q3 2024 Earnings Conference Call Transcript - Seeking Alpha
- 14 days ago - Genmab Announces Financial Results for the First Nine Months of 2024 - GlobeNewsWire
- 15 days ago - Genmab: Looking To Manage My Position Around Q3 Earnings - Seeking Alpha
- 15 days ago - Genmab to Present at Jefferies London Healthcare Conference - GlobeNewsWire
- 15 days ago - Genmab to Showcase Strength and Breadth of Comprehensive Epcoritamab-bysp Development Program at 2024 American Society of Hematology (ASH) Annual Meeting - Business Wire
- 5 weeks ago - Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2024 - GlobeNewsWire
- 6 weeks ago - Major Shareholder Announcement - GlobeNewsWire
- 7 weeks ago - Grant of Restricted Stock Units and Warrants to Employees in Genmab - GlobeNewsWire